Get involved

Claim

Opening the claim…

Comparing vaccine-against-placebo risk ratios between different trials, with no adjustment for how those trials differ, live attenuated vaccines (244,447 participants) are followed by fewer serious adverse events than placebo (risk ratio 0.92, 95% CI 0.88 to 0.97) and non-live vaccines (687,640) are not (1.00, 0.97 to 1.02), a ratio of the two of 0.93 (0.88 to 0.98, p = 0.0089); for reports of serious infections other than each vaccine's target the ratios are 0.94 (0.90 to 0.99) and 1.03 (0.98 to 1.08), a ratio of 0.92 (0.86 to 0.99, p = 0.021), which in trials of children is 0.91 (0.78 to 1.06, p = 0.22); and for death 0.84 (0.61 to 1.16) and 0.97 (0.93 to 1.02), a ratio of 0.86 (0.62 to 1.19, p = 0.36); no correction for the eight planned contrasts was planned, and a contrast between trials cannot show that the platform causes the difference. · sciencejournal.ai